Wednesday, August 06, 2025 | 02:25 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Kopran Share Price

Know More
BSENSE

158.25-14.25 (-8.26%)

04:01 PM, 12-Mar-2025
Stock not traded

BSE : 524280

NSE : KOPRAN

Sector : Health care

ISIN Code : INE082A01010

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 12-Mar-2025 | 04:01 PM IST

Market Cap (₹ Cr)

764

Traded Value (₹ Cr)

0.45

Volume (Shares)

28,719

Face Value (₹)

10

52-Week High (₹)

369.20

52-Week High Date

09-Sep-2024

52-Week Low (₹)

157.00

52-Week Low Date

17-Mar-2025

All Time High (₹)

558.84

All Time High Date

05-Dec-1994

All Time Low (₹)

6.40

All Time Low Date

23-Jan-2009

Kopran Ltd

Kopran was promoted by the Somani group and is controlled by Parijat Enterprises. The company came out with a public issue at a premium in Nov.'92 to finance its backward integration project to produce drug intermediates for semi-synthetic drugs and also to expand its antibiotic facility.Kopran manufactures pharmaceutical finished dosage forms and ...
Read More
BSE

Kopran Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Kopran Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230MH1958PLC011078</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>BBB+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CRISIL LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Sunil Sodhani <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: sunil@kopran.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Basant Kumar Soni <br/> Designation: Chief Financial Officer <br/> EmailId: bksoni@kopran.com</div> </div> <div> <br/> Date: 09/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

More

Kopran Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

764

EPS - TTM (₹) [C]

9.84

P/E Ratio (X) [C]

16.08

Face Value (₹) 10
Latest Dividend (%)30.00
Latest Dividend Date 04-Aug-2022
Dividend Yield (%) 1.89
Book Value Share (₹) [C]103.01
P/B Ratio (₹) [C]1.54

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Bandhan BSE Healthcare Index Fund - Regular (G) 0.01 384 0.04
Bandhan BSE Healthcare Index Fund - Direct (G) 0.01 384 0.04

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

157.70

164.95

Week Low/High (₹)

122.00

164.95

Month Low/High (₹)

122.00

164.95

Year Low/High (₹)

157.00

369.00

All time Low/High (₹)

6.40

559.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week17.70%25.36%22.97%27.64%
1 Month6.46%13.10%19.03%23.24%
3 Month-9.78%-4.16%19.93%24.47%
6 Month-21.39%-16.31%25.04%29.23%
1 Year-49.19%-46.01%24.11%27.96%
3 Year391.46%425.12%82.98%91.93%

Company Info

Company Information

Executive Vice Chairman : Surendra Somani

Company Sec. & Compli. Officer : Sunil Sodhani

Independent Director : Siddhan Subramanian

Independent Director : Sunita Banerji

Independent Director : Mamta Biyani

Independent Director : Narayan Atal

Chairman (Non-Executive) : Susheel Somani

Director : Adarsh Somani

Director : Varun Somani

Registered Office: Parijat House 1076, Dr E Moses Road Worli,Mumbai,Maharashtra-400018 Ph: 91-22-43661111

Email:investors@kopran.com

URL:http://www.kopran.com

FAQs about Kopran Ltd

1. What's the Kopran Ltd share price today?
Kopran Ltd share price was Rs 158.25 at 04:01 PM IST on 12th Mar 2025. Kopran Ltd share price was down by 8.26% from the previous closing price of Rs 172.50. Kopran Ltd share price trend:

  • Last 1 Month: Kopran Ltd share price moved up by 6.46% on BSE.
  • Last 3 Months: Kopran Ltd share price moved down by 9.78% on BSE.
  • Last 12 Months: Kopran Ltd share price moved down by 49.19% on BSE.
  • Last 3 Years: Kopran Ltd share price moved up by 391.46% on BSE.


2. How can I quickly analyse the performance of the Kopran Ltd stock?
The performance of the Kopran Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 16.08
  • Price to book value ratio is 1.54
  • Dividend yield of 1.89
  • The EPS (trailing 12 months) of the Kopran Ltd stock is Rs 9.84


3. What is the market cap of Kopran Ltd?
Kopran Ltd has a market capitalisation of Rs 764 crore.


4. What is Kopran Ltd's 52-week high/low share price?
The Kopran Ltd’s 52-week high share price is Rs 369.20 and 52-week low share price is Rs 157.00.


5. Is the Kopran Ltd profitable?
On a consolidated basis, Kopran Ltd reported a profit of Rs 10.40 crore on a total income of Rs 166.41 crore for the quarter ended 2024. For the year ended 2024, Kopran Ltd had posted a profit of Rs 50.96 crore on a total income of Rs 614.59 crore.


6. Which are Kopran Ltd’s peers in the Health care sector?
Kopran Ltd’s top 5 peers in the Health care sector are Lincoln Pharma., Shree Ganesh Rem, Anuh Pharma, Kopran, Bharat Parenter., NGL Fine Chem, Fermenta Biotec..


7. Who owns how much in Kopran Ltd?
Key changes to the Kopran Ltd shareholding are as follows:

  • Promoter holding in Kopran Ltd has gone up to 44.30 per cent as of Dec 2022 from 44.25 per cent as of Mar 2022.